Back Daily Mail FDA poised to approve $5 MILLION gene therapy to treat muscular atrophy
Search Sections 21 Aug
Close
Advertisement
FDA poised to approve $5 MILLION gene therapy to treat muscular atrophyUpdated17 May 11:33am

FDA poised to approve $5 MILLION gene therapy to treat muscular atrophy

Daily Mail
The FDA is expected to approve Zolgensma, the world's second gene therapy for spinal muscular atrophy. Expert's worry that the two drugs for the disease are setting an expensive precedent.
Read full story
 Like Comment
Advertisement

Comments

No comments yet...
On the top

Date settings

Today is Wednesday, August 21, 2019

+ 1 -
+ 1 -
+ 2016 -

Close

By using our website, you agree to the use of cookies as described in our cookie policy.

Accept

Daily Mail

Close